+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Canada DNA Vaccine Market 2019-2025

  • PDF Icon


  • February 2020
  • Region: Canada
  • Orion Market Research Private Limited
  • ID: 5116602
Canada DNA Vaccine Market Size, Share & Trends Analysis Report by Type (Animal DNA Vaccine and Human DNA Vaccine) By Technology (Plasmid DNA Vaccine and Plasmid DNA Delivery) By Application (Oncology, Infectious Disease, and Others) Forecast period (2019-2025).

Canada DNA Vaccine market is anticipated to grow at a CAGR 41.6% during the forecast period. There are various factors driving the growth of the DNA vaccination market in Canada. This includes increasing healthcare expenditure, investment by cancer research organizations and increasing prevalence of cancer. In May 2017, Canadian Gary kobinger has set to overcome the Zika virus by developing a DNA vaccine. Mice are used in the earlier test of the vaccine. Moreover, the experimental vaccine referred to as GLS-5700, protected all the mice from brain damage, zika infection and death. The vaccine also triggered a robust immune response in the monkeys. The vaccine is also expected to protect the child of pregnant women from Zika infection as well as protect it from microcephaly.

Apart from this, Dr. Weiner, specialized in DNA vaccines along with Dr.Kobinger has led the development of Ebola drug ZMapp at the National Microbiology Laboratory in Winnipeg. It is under phase 1 human trials regarding DNA vaccines for MERS and Ebola. Likewise, the studies for HIV have also conducted by Gary Kobinger at Canada's National Microbiology Laboratory in Winnipeg. It shows a high focus on R&D for DNA vaccination in Canada, which may result in widening the possibilities of the Canada DNA vaccination market for the effective treatment of several diseases.

Furthermore, an increased prevalence of cancer is also expected to augment the Canada DNA vaccination market. According to the Canadian Cancer Statistics, it was estimated that around 1 in 2 Canadian will have cancer in a lifetime. On the other hand, 1 out of 4 will have mortality due to cancer. The key market player that is active in the market includes Arbutus Biopharma Corp., Dendreon Pharmaceuticals LLC, GE Healthcare, GlaxoSmithKline PLC., Green Cross Corp., Innovio Biomedical Corp., Immunomic Therapeutics, Merck & Co., Pfizer Inc., Protein Sciences Corp., and Sanofi Inc. among other.

Research Methodology:

The market study of the Canada DNA Vaccine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. The Canada DNA Vaccine Market Research and Analysis by Type
2. The Canada DNA Vaccine Market Research and Analysis by Technology
3. The Canada DNA Vaccine Market Research and Analysis by Application

The Report Covers:
  • Comprehensive Research Methodology of the Canada DNA Vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Canada DNA Vaccine market.
  • Insights about market determinants which are stimulating the Canada DNA Vaccine market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Arbutus Biopharma Corp.
  • Dendreon Pharmaceuticals LLC
  • GE Healthcare
  • Glaxosmithkline PLC.
  • Immunomic Therapeutics
  • Innovio Biomedical Corp.
  • Merck & Co.
  • Pfizer Inc.
  • Protein Sciences Corp.
  • Sanofi Inc.